Article
Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease.
British journal of cancer - 15 Sept 2009
McAulay K A, Haque T, Crawford D H
Abstract excerpt
BACKGROUND: Epstein-Barr virus-positive post-transplant lymphoproliferative disease (PTLD) is a potentially lethal complication of iatrogenic immunosupression after transplantation. Predicting the development of PTLD allowing early and effective intervention is therefore of importance. Polymorphisms within cytokine genes are implicated in susceptibility to, and progression of, disease however the published data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
